| Breast cancer screening using tomosynthesis in combination with digital mammography SM Friedewald, EA Rafferty, SL Rose, MA Durand, DM Plecha, ... Jama 311 (24), 2499-2507, 2014 | 1038 | 2014 |
| Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI NM Braman, M Etesami, P Prasanna, C Dubchuk, H Gilmore, P Tiwari, ... Breast Cancer Research 19, 1-14, 2017 | 608 | 2017 |
| Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium JR Dietz, MS Moran, SJ Isakoff, SH Kurtzman, SC Willey, HJ Burstein, ... Breast cancer research and treatment 181 (3), 487-497, 2020 | 398 | 2020 |
| Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)–positive breast cancer N Braman, P Prasanna, J Whitney, S Singh, N Beig, M Etesami, ... JAMA network open 2 (4), e192561-e192561, 2019 | 281 | 2019 |
| Breast cancer screening using tomosynthesis and digital mammography in dense and nondense breasts EA Rafferty, MA Durand, EF Conant, DS Copit, SM Friedewald, ... Jama 315 (16), 1784-1786, 2016 | 235 | 2016 |
| 18F-FDG PET/CT for monitoring of treatment response in breast cancer S Avril, RF Muzic, D Plecha, BJ Traughber, S Vinayak, N Avril Journal of Nuclear Medicine 57 (Supplement 1), 34S-39S, 2016 | 132 | 2016 |
| Application of Raman spectroscopy to identify microcalcifications and underlying breast lesions at stereotactic core needle biopsy I Barman, NC Dingari, A Saha, S McGee, LH Galindo, W Liu, D Plecha, ... Cancer research 73 (11), 3206-3215, 2013 | 115 | 2013 |
| Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes D Plecha, S Bai, H Patterson, C Thompson, R Shenk Annals of surgical oncology 22, 4241-4246, 2015 | 104 | 2015 |
| Pelvic abscesses: CT-guided transrectal drainage. GS Gazelle, JR Haaga, TA Stellato, MW Gauderer, DT Plecha Radiology 181 (1), 49-51, 1991 | 88 | 1991 |
| COVID-19 pandemic impact on decreased imaging utilization: a single institutional experience KD Parikh, NH Ramaiya, EG Kikano, SH Tirumani, H Pandya, B Stovicek, ... Academic Radiology 27 (9), 1204-1213, 2020 | 86 | 2020 |
| Three-dimensional MR fingerprinting for quantitative breast imaging Y Chen, A Panda, S Pahwa, JI Hamilton, S Dastmalchian, DF McGivney, ... Radiology 290 (1), 33-40, 2019 | 76 | 2019 |
| NCCN Guidelines® insights: breast cancer screening and diagnosis, version 1.2023: featured updates to the NCCN guidelines TB Bevers, BL Niell, JL Baker, DL Bennett, E Bonaccio, MS Camp, ... Journal of the National Comprehensive Cancer Network 21 (9), 900-909, 2023 | 73 | 2023 |
| A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk … T Wan, BN Bloch, D Plecha, CIL Thompson, H Gilmore, C Jaffe, L Harris, ... Scientific reports 6 (1), 21394, 2016 | 68 | 2016 |
| Raman spectroscopy: a real-time tool for identifying microcalcifications during stereotactic breast core needle biopsies A Saha, I Barman, NC Dingari, S McGee, Z Volynskaya, LH Galindo, ... Biomedical optics express 2 (10), 2792-2803, 2011 | 65 | 2011 |
| Liver biopsy: effects of biopsy needle caliber on bleeding and tissue recovery. DM Plecha, DW Goodwin, DY Rowland, ME Varnes, JR Haaga Radiology 204 (1), 101-104, 1997 | 62 | 1997 |
| Diagnostic power of diffuse reflectance spectroscopy for targeted detection of breast lesions with microcalcifications JS Soares, I Barman, NC Dingari, Z Volynskaya, W Liu, N Klein, D Plecha, ... Proceedings of the National Academy of Sciences 110 (2), 471-476, 2013 | 57 | 2013 |
| Fast MRI breast cancer screening–Ready for prime time S Partovi, D Sin, Z Lu, L Sieck, H Marshall, R Pham, D Plecha Clinical Imaging 60 (2), 160-168, 2020 | 46 | 2020 |
| Journal club: neglecting to screen women between 40 and 49 years old with mammography: what is the impact on treatment morbidity and potential risk reduction? D Plecha, N Salem, M Kremer, R Pham, C Downs-Holmes, A Sattar, ... American Journal of Roentgenology 202 (2), 282-288, 2014 | 39 | 2014 |
| False-negative rates of breast cancer screening with and without digital breast tomosynthesis MA Durand, SM Friedewald, DM Plecha, DS Copit, LD Barke, SL Rose, ... Radiology 298 (2), 296-305, 2021 | 36 | 2021 |
| Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis? ME Kremer, C Downs-Holmes, RD Novak, JA Lyons, P Silverman, ... American Journal of Roentgenology 198 (5), 1218-1222, 2012 | 36 | 2012 |
